Sort
261,768 grants matching “gene therapy”
Biology and Therapy of High Risk Neuroblastoma
$2,006,380Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2012 · CA
Center on the Physics of Cancer Metabolism
$2,006,322Claudia Fischbach · Cornell University · U54 · FY2019 · CA
Broad Institute Center for Cancer Systems Biology
$2,006,126Todd R. Golub · Broad Institute, Inc. · U54 · FY2013 · CA
SPORE: Brain Tumore SPORE Grant
$2,006,093Mitchel S. Berger · University Of California, San Francisco · P50 · FY2016 · CA
Genome 3D organization as a determinant of cell-fate decisions
$2,005,990Pedro Rocha · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD
Improving the safety and efficacy of cell therapies
$2,005,762Malcolm K Brenner · Baylor College Of Medicine · U54 · FY2007 · HL
Developing Information Infrastructure Focused on Cancer Comparative Effectiveness
$2,005,467David Alan Fenstermacher · H. Lee Moffitt Cancer Ctr & Res Inst · RC2 · FY2009 · CA
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
$2,004,748Ted M. Dawson · Johns Hopkins University · P50 · FY2015 · NS
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
$2,004,748Ted M. Dawson · Johns Hopkins University · P50 · FY2016 · NS
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
$2,004,748Ted M. Dawson · Johns Hopkins University · P50 · FY2018 · NS
Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50)
$2,004,748Ted M. Dawson · Johns Hopkins University · P50 · FY2017 · NS
UCLA SPOTRIAS CENTER APPLICATION RENEWAL-PROGRAM PROJECT
$2,004,544Jeffrey L Saver · University Of California Los Angeles · P50 · FY2012 · NS
Harnessing the power of experimental genetic crosses and systems genetics to probe drug resistance in malaria
$2,004,499Michael T Ferdig · University Of Notre Dame · P01 · FY2021 · AI
Broad Institute Center for Cancer Systems Biology
$2,004,265Todd R. Golub · Broad Institute, Inc. · U54 · FY2013 · CA
A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia
$2,004,198David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2016 · HL
Gene Therapy for Alzheimer's Disease
$2,004,171Fred H Gage · Salk Institute For Biological Studies · P01 · FY2006 · AG
Cyclodextrin for Niemann-Pick Type C1 Disease
$2,003,778Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2015 · TR
CincY as a Treatment for Creatine Transporter Defect
$2,003,778Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2015 · TR
Chromatin Structure and Gene Expression
$2,003,769Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$2,003,668Roy S Herbst · Yale University · P50 · FY2021 · CA
Prospective Study of Breast Cancer Survivorship
$2,003,551Lawrence H Kushi · Kaiser Foundation Research Institute · R01 · FY2012 · CA
Activities Of Chemokines In Health and Disease
$2,003,524Joshua M Farber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
PICS: A New Horizon for Surgical Critical Care
$2,003,458Frederick A Moore · University Of Florida · P50 · FY2015 · GM
Statistical Methods for Integrative Genomics in Cancer
$2,003,427William James Gauderman · University Of Southern California · P01 · FY2022 · CA
The Phenomenology And Neurophysiology Of Juvenile Bipolar Disorder
$2,003,126Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2009 · MH